zoloft lawsuit

Jul 27, 2012 by edgarbartn89

FDA notified healthcare specialists about the availability of updated Healthcare Skilled and Patient Details Sheets for antidepressant medicines that had been the topic of Public Well being Advisory issued about the risk of suicidality (suicidal thinking or behavior) in adults becoming treated with antidepressant medications, like Zoloft.

In response to recent scientific publications that report the possibility of elevated risk of suicidal behavior in adults treated with antidepressants,like Zoloft, the FDA has issued a Public Well being Advisory to update patients and healthcare providers with the newest info on this topic. Even just before the publication of these current reports, FDA had already begun the approach of reviewing readily available data to decide whether there is an increased risk of suicidal behavior in adults taking antidepressants. The Agency has asked manufacturers to offer data from their trials using an approach comparable to that employed in the evaluation of the danger of suicidal behavior in the pediatric population taking antidepressants. This effort will involve hundreds of clinical trials and may take much more than a year to full.

The U.S. Food and Drug Administration (FDA) is updating the public on the use of selective serotonin reuptake inhibitor (SSRI) antidepressants by women throughout pregnancy and the potential risk of a rare heart and lung condition identified as persistent pulmonary hypertension of the newborn (PPHN). The initial Public Wellness Advisory in July 2006 on this prospective threat was based on a single published study. Considering that then, there have been conflicting findings from new scientific studies evaluating this possible threat, generating it unclear regardless of whether use of SSRIs, like Zoloft, in the course of pregnancy can lead to PPHN.

FDA has reviewed the further new study outcomes and has concluded that, given the conflicting outcomes from various research, it is premature to reach any conclusion about a feasible link between SSRI, like Zoloft, use in pregnancy and PPHN. FDA will update the SSRI drug labels to reflect the new information and the conflicting outcomes.

PPHN occurs when a newborn child does not adapt to breathing outside the womb. Newborns with PPHN may possibly require intensive care support such as a mechanical ventilator to enhance their oxygen level. If serious, PPHN can result in numerous organ harm, which includes brain damage, and even death.

Speak to a zoloft lawyer about your potential Zoloft claim.